دورية أكاديمية

INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

التفاصيل البيبلوغرافية
العنوان: INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
المؤلفون: Peyvandi, Flora, Cataland, Spero, Scully, Marie, Coppo, Paul, Knoebl, Paul, Hovinga, Johanna A. Kremer, Metjian, Ara, de la Rubia, Javier, Pavenski, Katerina, Edou, Jessica Minkue Mi, Callewaert, Filip, De Winter, Hilde
المصدر: Hematology, Transfusion and Cell Therapy ; volume 43, page S46-S47 ; ISSN 2531-1379
بيانات النشر: Elsevier BV
سنة النشر: 2021
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Hematology, Immunology and Allergy
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.htct.2021.10.1047
الإتاحة: https://doi.org/10.1016/j.htct.2021.10.1047Test
https://api.elsevier.com/content/article/PII:S2531137921011949?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2531137921011949?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.69904A22
قاعدة البيانات: BASE